𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regional variations in ovarian cancer incidence in the United States, 1992–1997

✍ Scribed by H. Irene Hall; Ko-Hui Tung; Joellyn Hotes; Pamela Logan; Holly L. Howe

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
295 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Race/ethnic variations in ovarian cancer
Race/ethnic variations in ovarian cancer mortality in the United States, 1992–1997
✍ Holly L. Howe; Ko-Hui Tung; Steven Coughlin; Rachel Jean-Baptiste; Joellyn Hotes 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

A n estimated 13,900 women in the U.S. were expected to die from ovarian cancer in 2001, 1 making it the most fatal malignancy of the female genital tract. 2 Ovarian cancer also is the fifth leading cause of cancer deaths among women. 3 Although these statistics are alarming, to our knowledge only a

Incidence of ovarian cancer by race and
Incidence of ovarian cancer by race and ethnicity in the United States, 1992–1997
✍ Marc T. Goodman; Holly L. Howe; Ko Hui Tung; Joellyn Hotes; Barry A. Miller; Ste 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

O varian cancer is the fifth most common cancer among U.S. women. 1 An estimated 23,400 new cases were expected to be diagnosed in the U.S. in 2001. As is the case for breast and endometrial cancers, ovarian cancer is more common among women in northern and central Europe, and North America compare

Descriptive epidemiology of ovarian canc
Descriptive epidemiology of ovarian cancer in the United States, 1992–1997
✍ Marc T. Goodman; Holly L. Howe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

T he North American Association of Central Cancer Registries (NAACCR), formerly the American Association of Central Cancer Registries, was formed in 1987 to create registration standards and to provide a forum for the promotion and advancement of registry activities. The NAACCR's activities have gro

Stage at diagnosis of ovarian cancer in
Stage at diagnosis of ovarian cancer in the United States, 1992–1997
✍ Marc T. Goodman; Catherine N. Correa; Ko-Hui Tung; Steven D. Roffers; Xiao Cheng 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

R%: relative percentage. a Malignant ovarian tumors exclude serous cystadenoma (8442), papillary cystadenoma (8451), papillary serous cystadenoma (8462), mucinous cystadenoma (8472), and papillary mucinous cystadenoma (8473). b Rates are per 100,000 and are age-adjusted to the 1970 United States sta

Incidence of extraovarian primary cancer
Incidence of extraovarian primary cancers in the United States, 1992–1997
✍ Steven D. Roffers; Xiao Cheng Wu; Carol Hahn Johnson; Catherine N. Correa; Holly 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

T he accurate classification of the primary site and histology of reportable malignancies by cancer registrars requires careful review of the medical records, especially pathology and surgery reports. The pathologic distinction between cancer of the ovary and cancer of extraovarian tissue can be dif